Hemophilia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Reliability and Validity of the Turkish Version of the PedHAL
Conditions:   Hemophilia;   Hemophilia A, Severe;   Hemophilia B Intervention:   Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Condition:   Hemophilia A With Inhibitor Intervention:   Drug: SCT800 and Daratumumab Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

Reliability and Validity of the Turkish Version of the PedHAL
Conditions:   Hemophilia;   Hemophilia A, Severe;   Hemophilia B Intervention:   Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Condition:   Hemophilia A With Inhibitor Intervention:   Drug: SCT800 and Daratumumab Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

Reliability and Validity of the Turkish Version of the PedHAL
Conditions:   Hemophilia;   Hemophilia A, Severe;   Hemophilia B Intervention:   Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Condition:   Hemophilia A With Inhibitor Intervention:   Drug: SCT800 and Daratumumab Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

Reliability and Validity of the Turkish Version of the PedHAL
Conditions:   Hemophilia;   Hemophilia A, Severe;   Hemophilia B Intervention:   Sponsor:   Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials

ITI Using SCT800 Combining Daratumumab or SCT800 Alone in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Condition:   Hemophilia A With Inhibitor Intervention:   Drug: SCT800 and Daratumumab Sponsors:   Institute of Hematology & Blood Diseases Hospital;   Sinocelltech Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials